Spiral Therapeutics: Valuation, Funding & Investors
Spiral Therapeutics is a biotechnology company developing novel therapeutics for inner ear disorders, leveraging targeted delivery and proprietary platform technologies to address hearing and balance conditions. The company is advancing a pipeline that includes SPT-2101 and is expanding its proprietary MICS™ platform to develop disease-modifying treatments for auditory system diseases.
Leadership & Board
- Current Number of Employees
- 13
- Current LinkedIn Followers
- 1,719
Latest Estimated Valuation
- Total Amount Raised
- $27M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $27M
- Latest Funding Round
- Series B
Employee Trend
Spiral Therapeutics had 13 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Spiral Therapeutics had 1,719 followers as of November 9, 2026. The number of followers increased by 3 (0.17%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Apr 14, 2026 | Series B | $27.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Gund Investment | Series B |
| Advanced Bionics | Series B |
| Ferring Ventures | Series B |
| Uni-Bio Science Group | Series B |
| Unnamed major global pharmaceutical company | Series B |
Similar Companies
A snapshot of private companies similar to Spiral Therapeutics, helping you discover and navigate related company profiles.
